Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1994 May;38(5):1178–1181. doi: 10.1128/aac.38.5.1178

Oral LY217896 for prevention of experimental influenza A virus infection and illness in humans.

F G Hayden 1, A R Tunkel 1, J J Treanor 1, R F Betts 1, S Allerheiligen 1, J Harris 1
PMCID: PMC188174  PMID: 8067760

Abstract

The efficacy and safety of oral LY217896 for prevention of experimental influenza A/Kawasaki/86 (H1N1) virus infection were assessed in susceptible males randomly assigned to receive LY217896 (75 mg) or placebo once daily for 7 days beginning 24 h prior to viral challenge. The rates of virus shedding (100% in both groups), days of viral shedding (3.1 +/- 1.3 for the LY217896 group; 2.8 +/- 1.3 for the placebo group), and titers of virus in nasal washings did not differ between the groups. Mild upper respiratory tract illness (72% in the LY217896 group; 69% in the placebo group) developed in similar proportions of each group. LY217896 was associated with asymptomatic rises in serum uric acid levels and was ineffective in modifying the virologic or clinical course of experimental influenza A (H1N1) virus infection.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Colacino J. M., DeLong D. C., Nelson J. R., Spitzer W. A., Tang J., Victor F., Wu C. Y. Evaluation of the anti-influenza virus activities of 1,3,4-thiadiazol-2-ylcyanamide (LY217896) and its sodium salt. Antimicrob Agents Chemother. 1990 Nov;34(11):2156–2163. doi: 10.1128/aac.34.11.2156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hayden F. G., Andries K., Janssen P. A. Safety and efficacy of intranasal pirodavir (R77975) in experimental rhinovirus infection. Antimicrob Agents Chemother. 1992 Apr;36(4):727–732. doi: 10.1128/aac.36.4.727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Hayden F. G., Rollins B. S., Hay A. J. Anti-influenza virus activity of the compound LY253963. Antiviral Res. 1990 Jul;14(1):25–38. doi: 10.1016/0166-3542(90)90063-d. [DOI] [PubMed] [Google Scholar]
  4. Sears S. D., Clements M. L. Protective efficacy of low-dose amantadine in adults challenged with wild-type influenza A virus. Antimicrob Agents Chemother. 1987 Oct;31(10):1470–1473. doi: 10.1128/aac.31.10.1470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Wyde P. R., Ambrose M. W., Meyer H. L., Gilbert B. E. Toxicity and antiviral activity of LY253963 against respiratory syncytial and parainfluenza type 3 viruses in tissue culture and in cotton rats. Antiviral Res. 1990 Oct-Nov;14(4-5):237–247. doi: 10.1016/0166-3542(90)90005-r. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES